To Evaluate Newly Developed Pictogram Cards and Their Utility in Improving Inhaler Techniques in Asthmatic Patients

Islamia University of Bahawalpur320 enrolled

Overview

To evaluate newly developed pictogram cards and their utility in improving inhaler techniques in asthmatic patients.

A prospective, open-label, randomized controlled clinical study. For this purpose, pictogram cards are designed for Metered Dose Inhalers (MDI) and Dry Powder Inhalers (DPI). The pictogram labels are designed and printed in colors with Urdu language and then attached to the inhaler devices as cards. The demographic, clinical, and medical data are collected from the patients and their medical files. Moreover, the different clinical measures are also evaluated in the recruited patients.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

320

Conditions

Asthma

Interventions

Counselling by the Trained PharmacistOTHER

The intervention group 1 is verbally counselled about the proper use of their inhaler devices.

Pictograms Cards and Counselling by the Trained PharmacistOTHER

The investigator developed pictogram cards for the use of inhalers (MDI and DPI) and pictogram cards are attached to the inhalers of patients in the intervention group with counselling by the trained pharmacist.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Asthmatic Patients, should take inhalers regularly for at least 3 months and come personally for re-fill. Exclusion Criteria: * Coexistence of other chronic respiratory conditions. * Those who were difficult to communicate.

Locations (1)

The Islamia University of Bahawalpur

Chak Four Hundred Fifty-four, Bahawalpur, Pakistan

Outcomes

Primary Outcomes

Proper/Improper use of inhaler

Determine the proper/improper use of inhaler via checklist. The dichotomous primary endpoint (Proper inhaler technique/ Improper Inhaler Technique). A participant is categorized as having proper inhaler technique if the score was 7/7 and improper technique if the score was \< 7.

Time frame: 12 weeks

Secondary Outcomes

Determine the adherence via a validated tool named the Medication Adherence Report Scale (MARS-5).

Adherence is the extent to which a person's behavior- taking medication, following a diet, and/or executing lifestyle changes- corresponds with the agreed recommendations from a healthcare provider. The adherence is measured via a validated tool named the Medication Adherence Report Scale (MARS-5). MARS-5 shows promise as a self-report tool for measuring patients' reports of their medication use across various illnesses. The score ranges from 5 to 25, where a higher MARS-5 score indicates higher self-reported adherence.

Time frame: 12 weeks

Determine the Asthma Control in the asthmatic patients via ACT questionnaire.

Asthma control is determined via ACT questionnaire. ACT scores range from 5-25 for the adult test and 0-27 for the child test. The higher the score, the better the asthma control. In both tests, a score of 20 or higher suggests your asthma is probably under control.

Time frame: 12 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.